RNU6-1018P

Across TCGA pan-cancer cohorts, RNU6-1018P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-1018P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1018P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1018P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

OV, CESC, and ESCA are the cancer types where RNU6-1018P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.272	0.542	.019	54	view →
CESC	OS	Tertile	All	0.013	0.875	<.001	36	view →
ESCA	OS	Tertile	III,IV	0.849	0.354	.019	18	view →
KIRC	DFS	Tertile	All	0.704	0.874	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-1018P–OV (DFS)

Open the OV breakdown →